Global Antibody Therapeutics Industry Development: Innovation-Driven Evolution and China’s Rise as an Emerging Global Force
View our Complimentary Blue Book
Antibody therapeutics, with their high specificity and clear targeting mechanisms, play a central role in treating cancer, autoimmune diseases, and other major conditions. The global development of antibody drugs has evolved from basic scientific discovery to clinical breakthroughs, with continuous iteration of key technologies and the emergence of landmark products, driving the industry from a single-mAb era toward diversified, engineered, and complex modalities. Fueled by growing demand, technological innovation, and structural upgrades, the global antibody market continues to expand steadily, with emerging categories such as ADCs and bispecific antibodies rising rapidly. Meanwhile, China’s antibody industry, supported by favorable policies, mature technological systems, international expansion, and enhanced end-to-end capabilities, is increasingly playing a greater role in the global biopharmaceutical landscape.
Download this complimentary Blue book to discover:
Industry Overview and Antibody Therapeutics Landscape:
A comprehensive introduction to antibody therapeutics, including core definitions, development history, industry chain structure, and R&D pipeline dynamics, providing a foundational understanding of how the sector has evolved into a key pillar of modern biopharmaceuticals.
Global Antibody Therapeutics Market and Future Outlook:
An in-depth analysis of the global antibody therapeutics market, covering market size, growth trajectory, competitive landscape, and future development trends, with insights into the key forces shaping long-term industry expansion.
Modality-Based Analysis of Antibody Therapeutics:
A systematic breakdown of major antibody modalities—including monoclonal antibodies, bispecific antibodies, ADCs, and other emerging formats—examining their development history, technological characteristics, clinical pipelines, and approved products, highlighting differentiated innovation pathways across modalities.
Global and China Industry Trends and Strategic Evolution:
A forward-looking assessment of the antibody therapeutics industry, focusing on globalization strategies, advances in next-generation technologies, and the ongoing localization and integration of the industry chain, with particular emphasis on China’s accelerating role in global innovation and commercialization.
Default PDF Reader
Register to Download the Blue Book To-go
60 YEARS OF INSIGHTS
Our Global Initiatives
ABOUT THE ANALYST
Evin WANG
Senior Project Manager of Frost & Sullivan China, participated in market research projects，focusing on medicine, medical device and medical service.
About Our Firm
Frost & Sullivan